Skip to main content
Signal8
Launch Terminal

Kardigan, Inc. (KARD)

Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Kardigan, Inc. logo

Kardigan, Inc.

NASDAQ:KARDHealthcare
+0.47%$12.80
AH Close$12.80+0.00%vs close
Mkt Cap$1.2B
Float38.46M
O/S93.5M
Inst Own61.2%
SI11.6%
Dilution
Kardigan, Inc. logoNASDAQ:KARD$12.80+0.47%
FormDescription
4
Statement of Changes in Beneficial Ownership
3
Initial Statement of Beneficial Ownership
13D/A
Beneficial Ownership Report (Active, Amended)
2
8-K
5.02,7.01,9.01
13G
Beneficial Ownership Report
13G
Beneficial Ownership Report
10-Q
Quarterly Report
8-K
2.02,9.01
13G/A
Beneficial Ownership Report (Amended)
13G
Beneficial Ownership Report
4
Statement of Changes in Beneficial Ownership
13G
Beneficial Ownership Report
13D
Beneficial Ownership Report (Active)
13D
Beneficial Ownership Report (Active)
4
Statement of Changes in Beneficial Ownership
3/A
Initial Statement of Beneficial Ownership
4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
8-K
5.03,9.01
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership

1-25 of 54